NFKB1 and atherosclerosis: SIRT1 exerts its action activating and deactivating factors such as NFκB, p53, p73, and SOD, suggesting that SIRT1 activation may be a promising strategy for treating chronic inflammatory diseases, such as atherosclerosis and COPD.